图书简介

Background and basics; 1 Robert Henderson, Richard Varcoe: The epidemiology and pathophysiology of coronary artery disease; 2 Toby Rogers, Kenneth Kent, and Augusto D. Pichard: The history of interventional cardiology; 3 Peter F. Ludman: Risk assessment and analysis of outcomes; 4 David H. Roberts: Vascular access: femoral versus radial; 5 Gurbir Bhatia, James Nolan: Radiation and percutaneous coronary intervention; 6 Rod Stables: The ?golden rules? of percutaneous coronary intervention; 7 Kevin O?Gallagher, Jonathan Byrne, and Philip MacCarthy: Routine management after percutaneous coronary intervention; 8 Ayman Al-Saleh and Sanjit Jolly: Trial design and interpretation: statistics in PCI; Percutaneous coronary intervention-related imaging; 9 David Adlam, Annette Maznyczka, and Bernard Prendergast: Angiography: indications and limitations; 10 Olivier Muller, Stephane Fournier, Bernard De Bruyne: Coronary physiology in clinical practice; 11 Hiromasa Otake, Yasuhiro Honda, and Peter J. Fitzgerald: The role of intravascular ultrasound in percutaneous coronary intervention; 12 Ravinay Bhindi and Keith M. Channon: Optical Coherence Tomography in Percutaneous Coronary Intervention; 13 A. Coenen, L.E. Swart, R.P.J. Budde, and K. Nieman: Coronary computed tomography for the interventionalist; 14 Theodoros D. Karamitsos and Stefan Neubauer: Cardiovascular magnetic resonance; Percutaneous coronary intervention by clinical syndrome; 15 Vasim Farooq and Patrick W. Serruys: Stable coronary artery disease: medical therapy versus percutaneous coronary intervention versus surgery; 16 Bashir Alaour, Michael Mahmoudi and Nick Curzen: Percutaneous coronary intervention in non-ST elevation acute coronary syndrome; 17 Zulfiquar Adam and Mark A. de Belder: Primary percutaneous coronary intervention for ST elevation myocardial infarction; 18 Divaka Perera and Natalia Briceno: Percutaneous coronary intervention in patients with impaired left ventricular function; Percutaneous coronary intervention by lesion and patient subsets; 19 Yves Louvard, Philippe Garot, Thomas Hovasse, Bernard Chevalier, and Thierry Lefevre: Coronary bifurcation stenting: state of the art; 20 Michael Mahmoudi, Nick Curzen, Christine Hughes, Bruno Farah, and Jean Fajadet: Percutaneous coronary intervention for unprotected and protected left main stem disease; 21 Colm G. Hanratty, James C. Spratt, Simon J. Walsh: Chronic total occlusions; 22 George Kassimis and Adrian P. Banning: Revascularisation in patients with diabetes mellitus; 23 Marko Noc and Peter Radsel: Out of Hospital Arrest: Role of PCI; Adjunctive drug therapies in percutaneous coronary intervention; 24 Vikram Khanna, Tony Gershlick and Nick Curzen: Current status of oralantiplatelet therapies; 25 Tim Lockie: Current status of GP IIb/IIIa inhibitors; 26 Stefanie Schupke, Steffen Massberg, and Adnan Kastrati: The role of bivalirudin in percutaneous coronary intervention; 27 Simon J. Corbett and Nick Curzen: Optimal medical therapy in percutaneous coronary intervention patients: statins and ACE inhibitors as disease-modifying agents; 28 Mikhail S. Dzeshka, Richard A. Brown, and Gregory Y.H. Lip: New Oral Anti-Coagulants (NOACs) and other Adjunctive Therapies; Complications of percutaneous coronary intervention; 29 Peter A. McCullough: Contrast-induced acute kidney injury; 30 Jaya Chandrasekhar, Adriano Caixeta, Philippe Genereux, George Dangas, and Roxana Mehran: In-stent restenosis in the drug-eluting stent era; 31 Nikesh Malik, Amerjeet Banning, and Tony Gershlick: Stent thrombosis; 32 Adam de Belder: Stent loss and retrieval; 33 Mark Gunning and Chee Wah Khoo: Coronary artery perforation; Special devices in percutaneous coronary intervention; 34 Adam de Belder, Martyn Thomas, and Emanuele Barbato: Rotational atherectomy; 35 Peter O?Kane and Simon Redwood: Laser; 36 Giovanni Luigi De Maria and Adrian P. Banning: Saphenous Vein Graft PCI, Distal Protection and no-reflow; 37 Adam J. Brown and Nick E. J. West: Bioresorbable Vascular Scaffolds; 38 Corrado Tamburino, Claudia Ina Tamburino and Sebastiano Imme: Access Sites and the TAVI Procedure; 39 Mohamed Abdel-Wahab and John Jose: Selection of TAVI Prostheses; 40 Muhammed Zeeshan Khawaja and Simon Redwood: Co-existent Coronary Artery Disease in Patients Undergoing TAVI: When and When Not to Treat; 41 Michael Bellamy and Christopher Baker: Transcatheter Mitral Valve Repair; 42 Ricardo Boix Garibo, Mohsin Uzzaman, Michael Ghosh-Dastidar, and Vinayak Bapat: Transcatheter Mitral Valve Replacement; Other Non-coronary percutaneous interventions; 43 Patrick A. Calvert, Bushra S. Rana, Roland Hilling-Smith, and David Hildick-Smith: Percutaneous device closure of atrial septal defect and patent foramen ovale; 44 Alec Vahanian, Dominique Himbert, Eric Brochet, Gregory Ducrocq, and Bernard Iung: Mitral balloon valvuloplasty; 45 Charles Knight, Saidi Mohiddin, and Constantinos O?Mahony: Alcohol septal ablation for obstructive hypertrophic cardiomyopathy; 46 Iqbal Malik and Mohamed Hamady: Carotid artery stenting; 47 Tim Betts: Left Atrial Appendage Occlusion; The Future; 48 Kenneth Chan, Manish Saxena, and Melvin D. Lobo: Novel Therapies for Hypertension; 49 Giora Weisz: Robotic PCI; 50 Fizzah Choudry and Anthony Mathur: Stem Cell Therapy and Delivery

Trade Policy 买家须知